| Literature DB >> 35366867 |
Ser Hon Puah1, Chee Yen Goh2, Chung Leung Chan3, Amy Kui Jie Teoh2, Hao Zhang3, Zhiqi Shen4, Lay Ping Neo2.
Abstract
BACKGROUND: Proper inhaler device usage is paramount for control of underlying obstructive airway disease. Hence, education to healthcare professionals who will eventually educate patients need to be done effectively. We developed an application for mobile devices for education on six medical inhaler devices, the metered-dose inhaler (MDI), Turbuhaler, Accuhaler, Breezhaler, Ellipta and Respimat, and studied if there were any difference between the application and the manufacturer's instructions on inhaler technique. The aim of this study is to see if inhaler education via a mobile phone app is comparable to manual instruction for health care professions.Entities:
Keywords: Asthma; Inhaler; Inhaler device; Mobile application
Mesh:
Year: 2022 PMID: 35366867 PMCID: PMC8976399 DOI: 10.1186/s12909-022-03302-0
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Fig. 1Randomization process during recruitment of participants
Fig. 2Mobile app interface
Baseline characteristics of enrolled participants
| All ( | Control group ( | Mobile app group ( | ||
|---|---|---|---|---|
| Female | 70 (78) | 33 (73%) | 37 (82%) | 0.31 |
| Age, median (IQR) | 21 (3) | 21 (5) | 21 (3) | 0.90 |
| Chinese | 67 (74%) | 36 (80%) | 31 (69%) | 0.11 |
| Malay | 9 (10%) | 6 (13%) | 3 (7%) | |
| Indian | 6 (7%) | 1 (2%) | 5 (11%) | |
| Others | 8 (9%) | 2 (5%) | 6 (13%) | |
| Apple | 60 (67%) | 28 (62%) | 32 (71%) | 0.37 |
| Android | 30 (33%) | 17 (38%) | 13 (29%) | |
| No experience using any inhalers | 67 (74%) | 33 (73%) | 34 (76%) | 0.64 |
| No experience teaching any inhaler | 41 (46%) | 21 (47%) | 20 (44%) | 0.45 |
Improvement in inhaler demonstration before and after interventions between both groups
| Device | Control group | Mobile app group | ||||
|---|---|---|---|---|---|---|
| Steps correctly demonstrated | Pre intervention | Post-intervention | Pre-intervention | Post-intervention | ||
| Accuhaler (Total points, 315) | 63 (20.0%) | 290 (92.1%) | 89 (28.3%) | 280 (88.9%) | ||
| Turbuhaler (Total points, 360) | 36 (10.0%) | 298 (82.8%) | 32 (8.9%) | 319 (88.6%) | ||
| Respimat (Total points, 315) | 35 (11.1%) | 263 (83.5%) | 24 (7.6%) | 265 (84.1%) | ||
| Breezhaler (Total points, 450) | 47 (10.4%) | 417 (92.7%) | 56 (12.4%) | 383 (85.1%) | ||
| Ellipta (Total points, 270) | 39 (14.4%) | 253 (93.7%) | 62 (23.0%) | 236 (87.4%) | ||
| MDI (Total points, 315) | 140 (44.4%) | 264 (83.8%) | 138 (43.8%) | 264 (83.8%) | ||
Total point improvement for each inhaler device post intervention
| Device | Control group | Mobile app group | |
|---|---|---|---|
| Accuhaler | 227 | 191 | 0.067 |
| Turbuhaler | 262 | 287 | 0.02 |
| Respimat | 228 | 241 | 0.665 |
| Breezhaler | 370 | 327 | < 0.01 |
| Ellipta | 214 | 174 | < 0.01 |
| MDI | 124 | 126 | 0.946 |
all scores are calculated based on improvement in total steps done correctly after intervention
Self-rated knowledge and confidence level
| Control group | Mobile app group | z | ||
|---|---|---|---|---|
| Knowledge level | 4.33 (0.68) | 4.73 (0.42) | −3.056 | < 0.01 |
| Confidence level (overall) | 3.95 (0.75) | 3.98 (0.73) | −0.184 | 0.85 |
App quality and app subjective rating
| Score | |
|---|---|
| Information | 4.52 |
| Aesthetics | 4.44 |
| Functionality | 4.47 |
| Engagement | 4.24 |
| Would you pay for the app | 2.2 |
How many times would you use the app in the next 12 months | 3.42 |
| Would you recommend this app | 4.51 |
| Overall rating | 3.98 |